{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T11:36:04Z","timestamp":1791459364199,"version":"4.3.4"},"reference-count":23,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["neuromodulationjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromodulation: Technology at the Neural Interface"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.neurom.2023.05.001","type":"journal-article","created":{"date-parts":[[2023,6,15]],"date-time":"2023-06-15T21:31:20Z","timestamp":1686864680000},"page":"1256-1262","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Intrathecal Drug Delivery Systems for Cancer Pain Control: Insights on Current Contemporary Practices in the US"],"prefix":"10.1016","volume":"26","author":[{"given":"Vasudha","family":"Goel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varun","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Blaes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amitabh","family":"Gulati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurom.2023.05.001_bib2","doi-asserted-by":"crossref","first-page":"E283","DOI":"10.36076\/ppj.2011\/14\/E283","article-title":"Comprehensive consensus based guidelines on intrathecal drug delivery systems in the treatment of pain caused by cancer pain","volume":"14","author":"Deer","year":"2011","journal-title":"Pain Phys"},{"key":"10.1016\/j.neurom.2023.05.001_bib3","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1093\/annonc\/mdp001","article-title":"Cancer-related pain: a pan-European survey of prevalence, treatment, and patient attitudes","volume":"20","author":"Breivik","year":"2009","journal-title":"Ann Oncol"},{"key":"10.1016\/j.neurom.2023.05.001_bib4","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1158\/1055-9965.EPI-08-0157","article-title":"Alcohol and breast cancer risk defined by estrogen and progesterone receptor status: a case-control study","volume":"17","author":"Deandrea","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.neurom.2023.05.001_bib5","series-title":"Cancer Pain Relief","year":"1986"},{"key":"10.1016\/j.neurom.2023.05.001_bib6","doi-asserted-by":"crossref","first-page":"e58","DOI":"10.1016\/S1470-2045(12)70040-2","article-title":"Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC","volume":"13","author":"Caraceni","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.neurom.2023.05.001_bib7","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0304-3959(01)00324-4","article-title":"Symptoms during cancer pain treatment following WHO-guidelines: a longitudinal follow-up study of symptom prevalence, severity and etiology","volume":"93","author":"Meuser","year":"2001","journal-title":"Pain"},{"key":"10.1016\/j.neurom.2023.05.001_bib8","doi-asserted-by":"crossref","first-page":"4040","DOI":"10.1200\/JCO.2002.02.118","article-title":"Randomized clinical trial of an implantable drug delivery system compared with comprehensive medical management for refractory cancer pain: impact on pain, drug-related toxicity, and survival","volume":"20","author":"Smith","year":"2002","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.neurom.2023.05.001_bib9","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1001\/jama.291.1.63","article-title":"Intrathecal ziconotide in the treatment of refractory pain in patients with cancer or AIDS: a randomized controlled trial","volume":"291","author":"Staats","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.neurom.2023.05.001_bib10","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/ner.12538","article-title":"The Polyanalgesic Consensus Conference (PACC): recommendations on intrathecal drug infusion systems best practices and guidelines","volume":"20","author":"Deer","year":"2017","journal-title":"Neuromodulation"},{"key":"10.1016\/j.neurom.2023.05.001_bib13","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1093\/annonc\/mdm056","article-title":"Prevalence of pain in patients with cancer: a systematic review of the past 40 years","volume":"18","author":"van den Beuken-van Everdingen","year":"2007","journal-title":"Ann Oncol"},{"key":"10.1016\/j.neurom.2023.05.001_bib14","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/pbc.24155","article-title":"Chemotherapy compliance in patients with osteosarcoma","volume":"60","author":"Bajpai","year":"2013","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.neurom.2023.05.001_bib15","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1002\/pon.4815","article-title":"Factors contributing to cancer-related suicide: a study of root-cause analysis reports","volume":"27","author":"Aboumrad","year":"2018","journal-title":"Psychooncology"},{"key":"10.1016\/j.neurom.2023.05.001_bib16","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/AAP.0000000000000251","article-title":"Prospective observational study of patient-controlled intrathecal analgesia: impact on cancer-associated symptoms, breakthrough pain control, and patient satisfaction","volume":"40","author":"Brogan","year":"2015","journal-title":"Reg Anesth Pain Med"},{"key":"10.1016\/j.neurom.2023.05.001_bib17","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1111\/ner.12759","article-title":"Retrospective analysis of intrathecal drug delivery: outcomes, efficacy, and risk for cancer-related pain at a high volume academic medical center","volume":"21","author":"Sayed","year":"2018","journal-title":"Neuromodulation"},{"key":"10.1016\/j.neurom.2023.05.001_bib18","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1213\/ANE.0000000000002903","article-title":"Intrathecal drug delivery systems for refractory pancreatic cancer pain: observational follow-up study over an 11-year period in a comprehensive cancer center","volume":"126","author":"Carvajal","year":"2018","journal-title":"Anesth Analg"},{"key":"10.1016\/j.neurom.2023.05.001_bib19","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000009714","article-title":"Palliative care with cervical intrathecal infusion and external pump for a late-stage cancer patient with refractory pain: a case report","volume":"97","author":"Ju","year":"2018","journal-title":"Med (Baltim)"},{"key":"10.1016\/j.neurom.2023.05.001_bib20","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.1549","article-title":"Assessment of health care utilization and cost of targeted drug delivery and conventional medical management vs conventional medical management alone for patients with cancer-related pain","volume":"2","author":"Stearns","year":"2019","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.neurom.2023.05.001_bib21","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1213\/ANE.0000000000004425","article-title":"Intrathecal drug delivery systems for cancer pain: an analysis of a prospective, multicenter product surveillance registry","volume":"130","author":"Stearns","year":"2020","journal-title":"Anesth Analg"},{"key":"10.1016\/j.neurom.2023.05.001_bib22","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1001\/jama.279.23.1877","article-title":"Management of pain in elderly patients with cancer. SAGE study group. Systematic assessment of geriatric drug use via epidemiology","volume":"279","author":"Bernabei","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.neurom.2023.05.001_bib23","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/SPC.0000000000000427","article-title":"Intrathecal therapy for pain in cancer patients","volume":"13","author":"Dupoiron","year":"2019","journal-title":"Curr Opin Support Palliat Care"},{"key":"10.1016\/j.neurom.2023.05.001_bib24","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1002\/pon.4218","article-title":"Sociodemographic inequalities in barriers to cancer pain management: a report from the American Cancer Society\u2019s Study of Cancer Survivors-II (SCS-II)","volume":"25","author":"Stein","year":"2016","journal-title":"Psychooncology"},{"key":"10.1016\/j.neurom.2023.05.001_bib25","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1177\/1049909119852928","article-title":"Attitudes of hospice providers regarding intrathecal targeted drug delivery for patients with cancer","volume":"36","author":"Warner","year":"2019","journal-title":"Am J Hosp Palliat Care"},{"key":"10.1016\/j.neurom.2023.05.001_bib26","doi-asserted-by":"crossref","first-page":"6047","DOI":"10.3390\/ijms20236047","article-title":"Bone pain in cancer patients: mechanisms and current treatment","volume":"20","author":"Zaj\u0105czkowska","year":"2019","journal-title":"Int J Mol Sci"}],"container-title":["Neuromodulation: Technology at the Neural Interface"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094715923006505?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094715923006505?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T18:50:52Z","timestamp":1697223052000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1094715923006505"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":23,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S1094715923006505"],"URL":"https:\/\/doi.org\/10.1016\/j.neurom.2023.05.001","relation":{},"ISSN":["1094-7159"],"issn-type":[{"value":"1094-7159","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intrathecal Drug Delivery Systems for Cancer Pain Control: Insights on Current Contemporary Practices in the US","name":"articletitle","label":"Article Title"},{"value":"Neuromodulation: Technology at the Neural Interface","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurom.2023.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 International Neuromodulation Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}